Peritumoral allergic response in epithelial ovarian carcinoma

Aims: Desmoplasia, intratumoral lymphocyte infiltration, and calcification within the tumor and peritoneum are quite common in advanced epithelial ovarian carcinoma. Peritumoral inflammatory reactions associated with hematologic paraneoplastic syndrome are extremely rare. Materials and Method: We describe in detail two cases of epithelial ovarian carcinoma associated with proliferation of Russell bodies and Mott cells in desmoplastic tumor stroma. Results: In the first case, monoclonal proliferation was diagnosed with intranuclear inclusions (Dutcher bodies) in plasma cells. Dutcher bodies were seen both in the tumoral tissue and bone marrow. Monoclonal gammopathy of undetermined significance (MGUS) was diagnosed with an IgM level less than 3 g/l and clonal paratrabecular lymphoplasmocytoid infiltrate less than 10% in the bone marrow. There were no light chain restrictions. Elevated beta 2 microglobulin level and anemia complicated the patients' survival. In the second case, because of desmoplasia the tumor volume did not decrease after the standard chemotherapy although a significant portion of the carcinomatous tissue disappeared. In this study, we checked the role of peritumoral allergic response prospectively in five epithelial ovarian carcinoma cases by actin, desmin, and lambda light chain immunohistochemical staining of the omentum. Conclusions: Further studies are necessary to show the relation between peritumoral hypersensivity reaction and HLA 1 antigen processing machinery to improve disease-specific survival in epithelial ovarian carcinoma.

Epithelial ovarian carcinoma; Beta 2 microglobulin; MGUS; Russel body; Dutcher body; Mott cell

[1] Kabukcuoglu S., Ozalp S.S., Oner U., Bildirici K., Yalcin O.T., Oge T. et al.: “Actin bundling protein fascin expression in ovarian neoplasms: comparison of histopathologic features of tumors obtained by the first and secondary cytoreduction surgeries”. Eur. J. Gynaecol. Oncol., 2006, 27, 123.

[2] Han L.Y., Fletcher M.S., Urbauer D.L., Mueller P., Landen C.N., Kamat A.A. et al.: “HLA Class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma”. Clin. Cancer Res., 2008, 14, 3372.

[3] Symowicz J.,Adley B.P., Gleason K.J., Johnson J.J., Ghosh S., Fishman D.A. et al.: “Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-Cadherin ectodomain shedding in ovarian carcinoma cells”. Cancer Res., 2007, 67, 2030.

[4] Kamat A.A., Fletcher M., Gruman L.M., Mueller P., Lopez A., Landen C.N. Jr. et al.: “The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer”. Clin. Cancer Res., 2006, 12, 1707.

[5] Hoskins E., Rodriqez-Canales J., Hewitt S.M., Elmasri W., Han J., Han S. et al.: “Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells”. Gynecol. Oncol., 2011, 122, 656.

[6] Kamat A.A., Baldwin M., Urbauer D., Dang D., Han L.Y., Goldwin A. et al.: “ Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker”. Cancer., 2010, 116, 1918.

[7] James D.G.: “Waldenstrom’s syndromes”. QJM, 2010, 103, 67.

[8] Rampisela D., Donner L.R.: “An unusual self-limited clonal Mott cell proliferation with lymphoplasmacytic lymphoma-like features in a child with the Wiskott-Aldrich syndrome and Von Recklinghausen’s neurofibromatosis”. Pathol. Res. Pract., 2010, 206, 467.

[9] LeBoit P.E., McCalmont T.H.: “Cutaneous lymphomas and leukemias”. In: Elder D., Elenitsas R., Jaworsky C., Johnson B. (eds.): Lever’s Histopathology of the skin. Philadelphia, Lippincott- Raven, 1997, 805.

[10] Hasegawa K., Kubota K., Hirai H., Imai Y., Midorikawa Y., Makuuchi M.: “Hepatocellular carcinoma followed by Waldenström’s macroglobulinemia: a case report”. Hepatogastroenterology, 2000, 47, 842.

[11] D’hermies F., Meyer A., Morel X., Halhal M., Vu T.A., Elmaleh C. et al.: “Conjunctival in situ carcinoma in a patient with Waldenström’s disease”. J. Fr. Ophtalmol., 2001, 24, 328.

[12] Siddiqui A., Melamed M.R., Abbi R., Ahmed T.: “Mucinous (colloid) carcinoma of urinary bladder following long-term cyclophosphamide therapy for Waldenström’s macroglobulinemia”. Am. J. Surg. Pathol., 1996, 20, 500.

[13] Irfan A., Kaptan K., Beyan C.: “A case of Waldenström’s macroglobulinemia preceeded by larynx carcinoma”. Am. J. Hematol., 2007, 82, 329.

[14] Ansel S.M., Kyle R.A., Reeder C.B., Fonseca R., Mikhael J.R., Morice W.G. et al.: “Diagnosis and management of Waldenström Macroglobulinemia: Mayo stratification of macroglobulinemia and risk adapted therapy (mSmart) guidelines”. Mayo. Clin. Proc., 2010, 85, 824.

[15] Compo E., Swerdlow S.H., Harris N.L., Pileri S., Stein H., Jaffe E.S.: “The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications”. Blood, 2011, 117, 5019.

[16] Satoskar A.A., Efebera Y., Hasan A., Brodsky S., Nadasdy G., Dogan A. et al.: “Strong transthyretin immunostaining: Potential pitfall in cardiac amyloid typing”. Am. J. Surg . Pathol., 2011, 35, 1685.

[17] Wu J.,Catalono E., Coppola D.: “Retroperitoneal fibrosis (Ormond’s disease): clinical pathologic study of eight cases”. Cancer Control., 2002, 9, 432.

[18] Corradi D., Maestri R., Palmisano A., Bosio S., Greco P., Manenti L. et al.: “ Idiopathic retroperitoneal fibrosis : clinicopathologic features and differential diagnosis”. Kidney Int., 2007, 72, 742.

[19] Yamamoto H., Yamaguchi H., Aishima S., Oda Y., Kohashi K., Oshiro Y. et al.: “Inflammatory myofibroblastic tumor versus Ig G4-related sclerosing disease and inflammatory pseudotumor”. Am. J. Surg. Pathol., 2009, 33, 1330.

[20] Von Bommel E.F.H., Mol M., Langerak A.W., Westenend P.J.: “Idiopathic retroperitoneal fibrosis mimicking malignant lymphoma”. Pathol. International., 2011, 61, 672.

[21] Shinozaki A., Ushiku T., Fukuyama M.: “Prominent Mott cell proliferation in Epstein-Barr virus associated gastric carcinoma”. Hum. Pathol., 2010, 41, 134.